CRSwNP Patient With
History of Asthma

DUPIXENT is approved for use in appropriate CRSwNP patients with or without prior sino-nasal surgery
Examples of patients with a history of asthma, previous sino-nasal surgery, or comorbid NSAID-ERD:
Nasal Congestion (NC) Score (0-3): 2
Nasal Polyp Score
(NPS)
(0-8):
6
SNOT-22 Score (0-110): 46
48 years old
Patient profile is representative and is not an actual DUPIXENT patient.
Nasal Congestion (NC) Score (0-3): 3
Nasal Polyp Score
(NPS)
(0-8):
6
SNOT-22 Score (0-110): 55
51 years old
Patient profile is representative and is not an actual DUPIXENT patient.
Bilateral Endoscopic Nasal
Polyp Score (NPS)
(0-8): 6
LMK-CT Score (0-24): 18
SNOT-22 Score (0-110): 55
FEV1: 60% of predicted
45 years old
Patient profile is representative and is not an actual DUPIXENT patient.
FEV1, forced expiratory volume in 1
second; ICS, inhaled corticosteroid; LABA,
long-acting beta agonist; LMK-CT, Lund-Mackay
computed tomography;
NC, nasal
congestion/obstruction; NPS, nasal polyp score;
NSAID-ERD, nonsteroidal anti-inflammatory
drug-exacerbated respiratory disease; OCS,
oral
corticosteroid; SNOT-22, 22-item Sino-Nasal Outcome
Test.
Discover if Your Patient is Right for DUPIXENT